Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor

Class:Id	LiteratureReference:9711776
_displayName	Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor
_timestamp	2021-01-13 21:46:53
author	[Person:9711817] Wang, Xiaoke [Person:9711876] Krishnan, Chandra [Person:9711779] Nguyen, Edward P [Person:9711803] Meyer, Kevin J [Person:9711806] Oliveira, Jennifer L [Person:5357953] Yang, Ping [Person:9711874] Yi, Eunhee S [Person:9711810] Erickson-Johnson, Michele R [Person:9711879] Yaszemski, Michael J [Person:9711792] Maran, Avudaiappan [Person:9711883] Oliveira, Andre M
created	[InstanceEdit:9711838] Rothfels, Karen, 2021-01-13
journal	Hum Pathol
pages	2047-52
pubMedIdentifier	22658521
title	Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor
volume	43
year	2012
(literatureReference)	[EntityWithAccessionedSequence:9711953] DCTN1(1-599)-p-7Y-ALK(1058-1620) fusion [cytosol] [Homo sapiens] [EntityWithAccessionedSequence:9711960] DCTN1(1-599)-ALK(1058-1620) fusion [cytosol] [Homo sapiens] [Reaction:9700179] Ligand-independent dimerization of ALK fusions [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor (9711776)